These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis. Jabbari A; Sansaricq F; Cerise J; Chen JC; Bitterman A; Ulerio G; Borbon J; Clynes R; Christiano AM; Mackay-Wiggan J J Invest Dermatol; 2018 Jul; 138(7):1539-1545. PubMed ID: 29452121 [TBL] [Abstract][Full Text] [Related]
5. Deciphering the Complex Immunopathogenesis of Alopecia Areata. Šutić Udović I; Hlača N; Massari LP; Brajac I; Kaštelan M; Vičić M Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891839 [TBL] [Abstract][Full Text] [Related]
6. Childhood Alopecia Areata: An Overview of Treatment and Recent Patents. Hon KL; Luk DCK; Leung AKC; Ng C; Loo SKF Recent Pat Inflamm Allergy Drug Discov; 2020; 14(2):117-132. PubMed ID: 32723274 [TBL] [Abstract][Full Text] [Related]
7. Topical and intralesional therapies for alopecia areata. Alkhalifah A Dermatol Ther; 2011; 24(3):355-63. PubMed ID: 21689245 [TBL] [Abstract][Full Text] [Related]
9. Alopecia areata: a tissue specific autoimmune disease of the hair follicle. Gilhar A; Kalish RS Autoimmun Rev; 2006 Jan; 5(1):64-9. PubMed ID: 16338213 [TBL] [Abstract][Full Text] [Related]
10. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study. Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507 [TBL] [Abstract][Full Text] [Related]
11. Mediation of alopecia areata by cooperation between CD4+ and CD8+ T lymphocytes: transfer to human scalp explants on Prkdc(scid) mice. Gilhar A; Landau M; Assy B; Shalaginov R; Serafimovich S; Kalish RS Arch Dermatol; 2002 Jul; 138(7):916-22. PubMed ID: 12071819 [TBL] [Abstract][Full Text] [Related]
12. Alopecia areata: infiltration of Th17 cells in the dermis, particularly around hair follicles. Tanemura A; Oiso N; Nakano M; Itoi S; Kawada A; Katayama I Dermatology; 2013; 226(4):333-6. PubMed ID: 23838575 [TBL] [Abstract][Full Text] [Related]
13. Alopecia areata: a review of disease pathogenesis. Rajabi F; Drake LA; Senna MM; Rezaei N Br J Dermatol; 2018 Nov; 179(5):1033-1048. PubMed ID: 29791718 [TBL] [Abstract][Full Text] [Related]
15. The current state of knowledge of the immune ecosystem in alopecia areata. Connell SJ; Jabbari A Autoimmun Rev; 2022 May; 21(5):103061. PubMed ID: 35151885 [TBL] [Abstract][Full Text] [Related]
16. Alopecia areata: Clinical presentation, diagnosis, and unusual cases. Finner AM Dermatol Ther; 2011; 24(3):348-54. PubMed ID: 21689244 [TBL] [Abstract][Full Text] [Related]
17. Lymphocytes, neuropeptides, and genes involved in alopecia areata. Gilhar A; Paus R; Kalish RS J Clin Invest; 2007 Aug; 117(8):2019-27. PubMed ID: 17671634 [TBL] [Abstract][Full Text] [Related]
18. Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis. Alkhalifah A; Alsantali A; Wang E; McElwee KJ; Shapiro J J Am Acad Dermatol; 2010 Feb; 62(2):177-88, quiz 189-90. PubMed ID: 20115945 [TBL] [Abstract][Full Text] [Related]
19. Alopecia areata: What's new in the epidemiology, comorbidities, and pathogenesis? Dainichi T; Iwata M; Kaku Y J Dermatol Sci; 2023 Dec; 112(3):120-127. PubMed ID: 37833164 [TBL] [Abstract][Full Text] [Related]
20. CCL13 is upregulated in alopecia areata lesions and is correlated with disease severity. Wang D; Xu X; Li X; Shi J; Tong X; Chen J; Lu J; Huang J; Yang S Exp Dermatol; 2021 May; 30(5):723-732. PubMed ID: 33523560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]